USP7 and nonpapillary renal cell carcinoma: We further depleted USP7 in OS-RC-2 and 786-O cells by shRNA or another USP7 inhibitor P22077 and confirmed that USP7 depletion sensitizes ccRCC cells to afatinib (Fig. 6c and Supplementary Fig. S5b).